Acute myeloid leukemia (AML) is a rare disease that is seen most often in older adults, although it can occur in younger people as well. This webinar discusses the symptoms of AML, how it is diagnosed, risk factors for developing AML, and current treatment options.

CAR T-cell therapy is a type of specialized immunotherapy that uses the patient's own modified T-cells to fight cancer. It is approved to treat certain blood cancers like lymphoma, leukemia, and multiple myeloma.

Un trasplante que utiliza las propias células madre del paciente (trasplante autólogo de células madre) o la terapia de células CAR T son opciones de tratamiento para pacientes con ciertos tipos de linfoma.

The COVID 19 pandemic has become an endemic disease that requires ongoing vigilance from stem cell transplant recipients. This presentation reviews current guidelines for when to test for COVID and the varieties of treatments that have become available since the onset of the virus.

Acute myeloid leukemia is a fast-moving cancer that can be fatal in weeks or months without treatment. This presentation reviews the causes, symptoms, and treatments for AML and recent progress in cure rates or prolonged remission for an increasing number of patients.

Genital graft-versus-host-disease can be a lifelong risk for female stem cell or bone marrow transplant recipients. The presentation reviews the symptoms of vaginal and vulvar GVHD and discusses treatments that can restore women to full sexual health and functioning.

Myelodysplastic syndrome (MDS) is a blood disorder that can develop into leukemia. There are several treatments for MDS, including stem cell transplantation. This presentation reviews key features of MDS, treatment options and when a transplant is an appropriate remedy.

There are several safe and effective vaccines for COVID-19. These vaccines are recommended for transplant patients in most circumstances. This presentation reviews guidelines, offers recommendations, and answers questions about the benefits of COVID-19 vaccines for transplant patients.

Esta es la Transcripción del seminario web Ser un Cuidador: Terapia de células CAR T, que se emitió el 1 de febrero de 2023.

Transcripción de la Presentación ( 00:00:01) (Julia Pan) Introducción. Bienvenidos al Seminario Web: Prevención y Tratamiento de la Enfermedad Injerto contra Huésped. Este Seminario Web es traído a usted por